Cargando…

Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations

COVID-19 pandemic caused by very severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) agent is an ongoing major global health concern. The disease has caused more than 452 million affected cases and more than 6 million death worldwide. Hence, there is an urgency to search for possible medica...

Descripción completa

Detalles Bibliográficos
Autores principales: Chtita, Samir, Belaidi, Salah, Qais, Faizan Abul, Ouassaf, Mebarka, AlMogren, Muneerah Mogren, Al-Zahrani, Ateyah A., Bakhouch, Mohamed, Belhassan, Assia, Zaki, Hanane, Bouachrine, Mohammed, Lakhlifi, Tahar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. on behalf of King Saud University. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296233/
https://www.ncbi.nlm.nih.gov/pubmed/35875823
http://dx.doi.org/10.1016/j.jksus.2022.102226
_version_ 1784750227258867712
author Chtita, Samir
Belaidi, Salah
Qais, Faizan Abul
Ouassaf, Mebarka
AlMogren, Muneerah Mogren
Al-Zahrani, Ateyah A.
Bakhouch, Mohamed
Belhassan, Assia
Zaki, Hanane
Bouachrine, Mohammed
Lakhlifi, Tahar
author_facet Chtita, Samir
Belaidi, Salah
Qais, Faizan Abul
Ouassaf, Mebarka
AlMogren, Muneerah Mogren
Al-Zahrani, Ateyah A.
Bakhouch, Mohamed
Belhassan, Assia
Zaki, Hanane
Bouachrine, Mohammed
Lakhlifi, Tahar
author_sort Chtita, Samir
collection PubMed
description COVID-19 pandemic caused by very severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) agent is an ongoing major global health concern. The disease has caused more than 452 million affected cases and more than 6 million death worldwide. Hence, there is an urgency to search for possible medications and drug treatments. There are no approved drugs available to treat COVID-19 yet, although several vaccine candidates are already available and some of them are listed for emergency use by the world health organization (WHO). Identifying a potential drug candidate may make a significant contribution to control the expansion of COVID-19. The in vitro biological activity of asymmetric disulfides against coronavirus through the inhibition of SARS-CoV-2 main protease (Mpro) protein was reported. Due to the lack of convincing evidence those asymmetric disulfides have favorable pharmacological properties for the clinical treatment of Coronavirus, in silico evaluation should be performed to assess the potential of these compounds to inhibit the SARS-CoV-2 Mpro. In this context, we report herein the molecular docking for a series of 40 unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitor. The optimal binding features of disulfides within the binding pocket of SARS-CoV-2 endoribonuclease protein (Protein Data Bank [PDB]: 6LU7) was described. Studied compounds were ranked for potential effectiveness, and those have shown high molecular docking scores were proposed as novel drug candidates against SARS-CoV-2. Moreover, the outcomes of drug similarity and ADME (Absorption, Distribution, Metabolism, and Excretion) analyses have may have the effectiveness of acting as medicines, and would be of interest as promising starting point for designing compounds against SARS-CoV-2. Finally, the stability of these three compounds in the complex with Mpro was validated through molecular dynamics (MD) simulation, in which they displayed stable trajectory and molecular properties with a consistent interaction profile.
format Online
Article
Text
id pubmed-9296233
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Author(s). Published by Elsevier B.V. on behalf of King Saud University.
record_format MEDLINE/PubMed
spelling pubmed-92962332022-07-20 Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations Chtita, Samir Belaidi, Salah Qais, Faizan Abul Ouassaf, Mebarka AlMogren, Muneerah Mogren Al-Zahrani, Ateyah A. Bakhouch, Mohamed Belhassan, Assia Zaki, Hanane Bouachrine, Mohammed Lakhlifi, Tahar J King Saud Univ Sci Original Article COVID-19 pandemic caused by very severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) agent is an ongoing major global health concern. The disease has caused more than 452 million affected cases and more than 6 million death worldwide. Hence, there is an urgency to search for possible medications and drug treatments. There are no approved drugs available to treat COVID-19 yet, although several vaccine candidates are already available and some of them are listed for emergency use by the world health organization (WHO). Identifying a potential drug candidate may make a significant contribution to control the expansion of COVID-19. The in vitro biological activity of asymmetric disulfides against coronavirus through the inhibition of SARS-CoV-2 main protease (Mpro) protein was reported. Due to the lack of convincing evidence those asymmetric disulfides have favorable pharmacological properties for the clinical treatment of Coronavirus, in silico evaluation should be performed to assess the potential of these compounds to inhibit the SARS-CoV-2 Mpro. In this context, we report herein the molecular docking for a series of 40 unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitor. The optimal binding features of disulfides within the binding pocket of SARS-CoV-2 endoribonuclease protein (Protein Data Bank [PDB]: 6LU7) was described. Studied compounds were ranked for potential effectiveness, and those have shown high molecular docking scores were proposed as novel drug candidates against SARS-CoV-2. Moreover, the outcomes of drug similarity and ADME (Absorption, Distribution, Metabolism, and Excretion) analyses have may have the effectiveness of acting as medicines, and would be of interest as promising starting point for designing compounds against SARS-CoV-2. Finally, the stability of these three compounds in the complex with Mpro was validated through molecular dynamics (MD) simulation, in which they displayed stable trajectory and molecular properties with a consistent interaction profile. The Author(s). Published by Elsevier B.V. on behalf of King Saud University. 2022-10 2022-07-20 /pmc/articles/PMC9296233/ /pubmed/35875823 http://dx.doi.org/10.1016/j.jksus.2022.102226 Text en © 2022 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Chtita, Samir
Belaidi, Salah
Qais, Faizan Abul
Ouassaf, Mebarka
AlMogren, Muneerah Mogren
Al-Zahrani, Ateyah A.
Bakhouch, Mohamed
Belhassan, Assia
Zaki, Hanane
Bouachrine, Mohammed
Lakhlifi, Tahar
Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations
title Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations
title_full Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations
title_fullStr Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations
title_full_unstemmed Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations
title_short Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations
title_sort unsymmetrical aromatic disulfides as sars-cov-2 mpro inhibitors: molecular docking, molecular dynamics, and adme scoring investigations
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296233/
https://www.ncbi.nlm.nih.gov/pubmed/35875823
http://dx.doi.org/10.1016/j.jksus.2022.102226
work_keys_str_mv AT chtitasamir unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations
AT belaidisalah unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations
AT qaisfaizanabul unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations
AT ouassafmebarka unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations
AT almogrenmuneerahmogren unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations
AT alzahraniateyaha unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations
AT bakhouchmohamed unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations
AT belhassanassia unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations
AT zakihanane unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations
AT bouachrinemohammed unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations
AT lakhlifitahar unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations